z-logo
Premium
Investigating the Role of the Human Parvovirus B19's Main Viral Protein, NS1, in Viral Replication and Interactions with Host DNA
Author(s) -
Hernandez Christian Joab,
Sanchez Jonathan Lares,
Horton Nancy C.
Publication year - 2017
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.31.1_supplement.912.16
Subject(s) - biology , transactivation , virology , viral replication , parvovirus , genome , capsid , dna virus , virus , gene , genetics , gene expression
Human Parvovirus B19 (B19V) is a ubiquitous virus that infects the majority of the human population. B19V is a non‐enveloped, single stranded DNA virus with a viral genome composed of 5594 nucleotides. Infection with B19V has been associated with a multitude of diseases, such as hydrops fetalis, arthropathy, hepatitis, cardiomyopathy, erythema infectiosum (Fifth disease), and possible onset of a variety of autoimmune diseases. The viral genome of B19V encodes for five known, possible six, protein products: VP1 and VP2 that compose the capsid, NS1, the main viral protein, and two to three smaller protein products of indistinct function. The main replicative protein, NS1, is a multiple domain protein with a nuclease domain, helicase domain, and a C‐terminal domain. Through its multi‐functional capabilities, NS1 has been hypothesized to play several roles in the triggering autoimmune disease via formation of covalent DNA‐NS1 adducts and/or host gene transactivation. In order to understand the mechanism behind NS1's ability to bind viral and host genomic DNA, biochemical experiments were carried out to build a model for NS1's role in viral genome replications and host gene transactivation capabilities. Support or Funding Information Supported by: the National Science Foundation under Grant MCB1410355, and National Institutes of Health via Grant S10OD013237

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here